Shares of NASDAQ:ONVO opened at $0.49 on Monday. Organovo has a 52-week low of $0.32 and a 52-week high of $1.74. The stock has a market cap of $7.48 million, a price-to-earnings ratio of -0.46 ...
(RTTNews) - Organovo Holdings, Inc. (ONVO), a clinical-stage biotech firm focused on advancing innovative treatments for inflammatory bowel disease, on Monday announced the appointment of Norman ...
SAN DIEGO - Organovo Holdings, Inc. (NASDAQ:ONVO), a biotechnology firm engaged in the development of treatments for inflammatory bowel disease and other conditions, announced the appointment of ...
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel ...
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback